価格表

在庫・価格 : 2025年11月03日 19時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human IL-2 MAb (Clone 5334)
データシート※最新のデータシートでない場合があります
MAB202-100 RSDアールアンドディー システムズ
R&D Systems, Inc.
100 μg ¥83,000 1個 追加

在庫・価格 : 2025年11月03日 19時43分 現在

Anti-Human IL-2 MAb (Clone 5334)

  • 商品コード:MAB202-100
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥83,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 G端ler A et al. Suppressor of cytokine signalling 3 is crucial for interleukin-7 receptor re-expression after T-cell activation and interleukin-7 dependent proliferation. Eur J Immunol 2020 02;50(2):234-244
G端ler A et al
2020/01/01
Species: Human, Applications: Neutralization PubMed
2 Karenko L et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res. 2005 Sep;65(18):8101-10
Karenko L et al
2005/01/01
Species: Human, Applications: Flow Cytometry PubMed
3 Nata T et al. Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum. J. Biol. Chem. 2015 Sep;290(37):22338-51
Nata T et al
2015/01/01
Species: Human, Applications: Neutralization PubMed
4 Sen Y et al. Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells. Immunology 2004 Jun;112(2):274-89
Sen Y et al
2004/01/01
Species: Human, Applications: Flow Cytometry PubMed
5 Revu S et al. IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation. Cell Rep 2018 Mar;22(10):2642-2653
Revu S et al
2018/01/01
Species: Human, Applications: Neutralization PubMed
6 Kim DW et al. Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells. J Transl Med 2014;12:113
Kim DW et al
2014/01/01
Species: Human, Applications: Neutralization PubMed
7 Carmenate T et al. Blocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells. J. Immunol. 2018 May;200(10):3475-3484
Carmenate T et al
2018/01/01
Species: Human, Applications: Bioassay PubMed
8 Withers DR et al. T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. Blood 2007 Jun;109(11):4856-64
Withers DR et al
2007/01/01
Species: Human, Applications: Neutralization PubMed
9 Hutnick NA et al. Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive. Vaccine 2010 Feb;28(8):1932-41
Hutnick NA et al
2010/01/01
Species: Human, Applications: Flow Cytometry PubMed
10 Herrero C et al. Reprogramming of IL-10 activity and signaling by IFN-gamma. J. Immunol. 2003 Nov;171(10):5034-41
Herrero C et al
2003/01/01
Species: Human, Applications: Neutralization PubMed
11 Kim JH et al. Effects of pepsin and pepstatin on reflux tonsil hypertrophy in vitro. PLoS ONE 2018;13(11):e0207090
Kim JH et al
2018/01/01
Species: Human, Applications: Neutralization PubMed
12 Jiang J et al. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep 2016 Sep;6:32320
Jiang J et al
2016/01/01
Species: Human, Applications: Flow Cytometry PubMed
13 Weissm端ller S et al. ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation. Blood 2012 Jun;119(26):6268-77
Weissm端ller S et al
2012/01/01
Species: Human, Applications: Neutralization PubMed
14 Locci M et al. Activin A programs the differentiation of human TFH cells. Nat. Immunol. 2016 Aug;17(8):976-84
Locci M et al
2016/01/01
Species: Human, Applications: Bioassay PubMed
  • No.: 1
  • 文献情報:
    G端ler A et al. Suppressor of cytokine signalling 3 is crucial for interleukin-7 receptor re-expression after T-cell activation and interleukin-7 dependent proliferation. Eur J Immunol 2020 02;50(2):234-244
    G端ler A et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Karenko L et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res. 2005 Sep;65(18):8101-10
    Karenko L et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Nata T et al. Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum. J. Biol. Chem. 2015 Sep;290(37):22338-51
    Nata T et al
    2015/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Sen Y et al. Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells. Immunology 2004 Jun;112(2):274-89
    Sen Y et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Revu S et al. IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation. Cell Rep 2018 Mar;22(10):2642-2653
    Revu S et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Kim DW et al. Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells. J Transl Med 2014;12:113
    Kim DW et al
    2014/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Carmenate T et al. Blocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells. J. Immunol. 2018 May;200(10):3475-3484
    Carmenate T et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Bioassay
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Withers DR et al. T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. Blood 2007 Jun;109(11):4856-64
    Withers DR et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Hutnick NA et al. Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive. Vaccine 2010 Feb;28(8):1932-41
    Hutnick NA et al
    2010/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Herrero C et al. Reprogramming of IL-10 activity and signaling by IFN-gamma. J. Immunol. 2003 Nov;171(10):5034-41
    Herrero C et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Kim JH et al. Effects of pepsin and pepstatin on reflux tonsil hypertrophy in vitro. PLoS ONE 2018;13(11):e0207090
    Kim JH et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Jiang J et al. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep 2016 Sep;6:32320
    Jiang J et al
    2016/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Weissm端ller S et al. ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation. Blood 2012 Jun;119(26):6268-77
    Weissm端ller S et al
    2012/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Locci M et al. Activin A programs the differentiation of human TFH cells. Nat. Immunol. 2016 Aug;17(8):976-84
    Locci M et al
    2016/01/01
  • 備考:
    Species: Human, Applications: Bioassay
  • 参照:
    PubMed